Français
ItalianoBond Royalty Pharma 4.45% ( US78081BAT08 ) in USD
| Issuer | Royalty Pharma | ||||||||||||||
| Market price |  99.54 % ▼ |
||||||||||||||
| Country |  United States
|
||||||||||||||
| ISIN code |
 US78081BAT08 ( in USD )
|
||||||||||||||
| Interest rate | 4.45% per year ( payment 2 times a year) | ||||||||||||||
| Maturity | 25/03/2031 | ||||||||||||||
|
Prospectus brochure in PDF format |
|||||||||||||||
| Minimal amount | / | ||||||||||||||
| Total amount | / | ||||||||||||||
| Cusip | 78081BAT0 | ||||||||||||||
| Standard & Poor's ( S&P ) rating | BBB- ( Lower medium grade - Investment-grade ) | ||||||||||||||
| Moody's rating | Baa2 ( Lower medium grade - Investment-grade ) | ||||||||||||||
| Next Coupon | 25/09/2026 ( In 9 days ) | ||||||||||||||
| Detailed description |
Royalty Pharma is a biopharmaceutical company that invests in and manages royalties from marketed pharmaceutical and biotechnology products. The Bond issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAT08, pays a coupon of 4.45% per year. The coupons are paid 2 times per year and the Bond maturity is 25/03/2031 The Bond issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAT08, was rated Baa2 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAT08, was rated BBB- ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||
| |||||||||||||||